07/11/2026
THC can help many people.
Despite negativity towards the cannabinoid in studies and healthcare, we can’t deny that it’s a powerful and helpful plant constituent. THC has helped open doors in pain, sleep, nausea, appetite, trauma, epilepsy, and so many other areas of plant medicine. But when someone uses THC every day and only leans into one lane of the plant, vs. the 3 majors we have, their ECS can start getting out of balance.
That’s where the raw cannabinoids matter.
CBGa and CBDa are not just “unfinished” cannabinoids waiting to become CBG and CBD. They’re part of the plant’s original chemistry, and for many daily THC users, they may be exactly the kind of support the body needs. THC pushes CB1 activity hard. That can be helpful, but over time heavy daily use may lead to tolerance, downregulation, and the feeling that cannabis isn’t working like it used to.
The answer isn’t always more THC.
Sometimes the answer is better support.
CBGa and CBDa bring non-intoxicating balance into the conversation. Research on acidic cannabinoids points toward anti-inflammatory, anticonvulsant, neuroprotective, anti-nausea, and other therapeutic potential. CBDa has also been studied for COX-2 inhibition and serotonin-related pathways, while CBGa has been studied for inflammation, cellular stress, ion channels, and metabolic pathways.
That matters because daily THC users often aren’t just chasing a high. Many are managing pain, stress, sleep, appetite, inflammation, trauma, or a nervous system that’s been running too hot for too long.
THC is a powerful tool.
But tools work better in a full toolbox.
For many people who use THC daily, CBGa and CBDa may help bring the raw plant back into the plan, supporting the ECS without always pushing it harder.
Cannabis medicine isn’t one cannabinoid.
It’s balance.
Mike Robinson, Researcher OG
Therapeutic potential of acidic cannabinoids: an update
https://pmc.ncbi.nlm.nih.gov/articles/PMC12895846/